Online Program

287543
Mixed-methods exploration of fear as a multi-level barrier to voluntary partner notification among men who have sex with men (MSM) recently diagnosed with HIV/STI in lima, Peru (2011)


Tuesday, November 5, 2013

Amaya Perez-Brumer, BA, Division of Infectious Diseases, David Geffen School of Medicine, UCLA Program in Global Health, Lima, Peru
Eddy Segura, MD, MPH, Division of Infectious Diseases, David Geffen School of Medicine, UCLA Program in Global Health, Lima, Peru
S. Bryn Austin, ScD, Department of Social and Behavioral Sciences, Harvard T.H. Chan School of Public Health, Boston, MA
H. Javier Salvatierra, MD, Ministerio de Salud, Dirección Regional de Salud I-Callao,, Lima, Peru
Jesus Peinado, MD, MS, Asociación Civil Impacta Salud y Educación, Barranco, Lima, Peru
Javier R. Lama, MD, MPH, Asociación Civil Impacta Salud y Educación, Barranco, Lima, Peru
Jorge Sanchez, MD, MPH, Asociación Civil Impacta Salud y Educación, Barranco, Lima, Peru
Jesse Clark, MD, MS, Division of Infectious Diseases, David Geffen School of Medicine, UCLA Program in Global Health, Lima, Peru
BACKGROUND: Partner management strategies in Peru depend on first-party notification following HIV/STI diagnosis. We explored the relationship between “fear” and anticipated HIV/STI disclosure among recently diagnosed MSM in low-income, urban Peru. METHODS: Through behavioral surveys and in-depth interviews, we assessed anticipated partner notification among MSM diagnosed with HIV/STIs in the past month. A subset of participants (n=30) were selected for semi-structured interviews. Quantitative and qualitative analysis assessed different types of “Fear”, and differentiated between individual- and partner-level factors. RESULTS: Study participants (n=396) reported 1069 sex partnerships in 6 months and 46.3% did not anticipate notifying a recent partnership. In 46.0% of partnerships, “Fear” was reported as a reason for non-disclosure. Specific pathways included partner-level factors like fear of rejection (27.3%), fear of violence (24.1%), and social-level factors like fear of community awareness of their diagnosis (21.1%). Among participants (n=207) who cited fear as a barrier to notifying one or more partners, 70.9% cited partner-level factors and 42.8% cited social-level factors. Interviews also suggested that fear functioned as a barrier on multiple levels. Interpersonal barriers included fear of rejection or violence from recent partners and social barriers included anticipated violence, discrimination or rejection by peers and community members. CONCLUSIONS: Anticipated negative sentiments on both partnership and societal levels influenced willingness of Peruvian MSM to notify their recent sex partners of recent HIV/STI diagnosis. Further research is needed to explore the multiple pathways in which fear may influence partner notification to inform future interventions to control secondary HIV/STI transmission.

Learning Areas:

Epidemiology
Public health or related research
Social and behavioral sciences

Learning Objectives:
Discuss how Peruvian MSM report fear(s) of an anticipated negative reactions, on multiple domains, as a barrier to voluntary partner notification following recent HIV/STI diagnosis. Identify the need to further assess how fear hinders HIV/STI status disclosure to improve current first-party notification strategies for MSM in Peru.

Keyword(s): HIV/AIDS, Latin American

Presenting author's disclosure statement:

Qualified on the content I am responsible for because: I am a current Masters of Science candidate at the Harvard School of Public Health with more than 5 years experience working on behavioral HIV/STI prevention interventions among have men who have sex with men (MSM) and transgender women in Peru and in the United States. Among my scientific interests has been the development of multidisciplinary strategies for the prevention of HIV/STI and mixed-methods evaluation of current HIV/STI interventions.
Any relevant financial relationships? No

I agree to comply with the American Public Health Association Conflict of Interest and Commercial Support Guidelines, and to disclose to the participants any off-label or experimental uses of a commercial product or service discussed in my presentation.